Research Progresses on Bundibugyo Ebola Vaccine Candidate Amid DRC Outbreak

Researchers at The University of Texas Medical Branch have made progress in developing a vaccine for the Bundibugyo Ebola virus. This advancement comes as global health officials address a growing outbreak in the Democratic Republic of the Congo. Study findings indicate the vaccine candidate protected nonhuman primates, establishing a foundation for potential future clinical trials, with the WHO prioritizing its further evaluation.